Back to Rankings

HUMA

HumacyteF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
HUMA vs peer average
40/100
HUMA vs. peer average (F vs. D)
Grade spread
C 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MENS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $176.38M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMENSJyong Biotech
HUMA
Humacyte
MENS
Jyong Biotech
Grade
F
F
Momentum
13
1
Value
41
46
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs MENS

HUMA / MENS
Grade Position
Below peers
HUMA vs. peer average (F vs. D)
40/100
Momentum
13
HUMA
Value
41
MENS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HUMA
1
MENS
Jyong Biotech Ltd Common
F
20/100
Even
2
TNYA
Tenaya Therapeutics Inc Common
C
60/100
-2
3
QSI
Quantum-Si Inc Class A Common
F
20/100
Even
4
LFCR
Lifecore Biomedical Inc Common
F
20/100
Even
5
NRXP
NRX Pharmaceuticals Inc Common
D
40/100
-1
MENS is the first peer returned for this comparison set.